相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diet and physical exercise in psoriasis: a randomized controlled trial
L. Naldi et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
The effect of weight loss surgery on the severity of psoriasis
E. W. Hossler et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy
F. Iannone et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2013)
Effect of Weight Loss on the Severity of Psoriasis A Randomized Clinical Study
Peter Jensen et al.
JAMA DERMATOLOGY (2013)
Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: Long-term results from a phase 2/3 clinical trial
Atsuyuki Igarashi et al.
JOURNAL OF DERMATOLOGY (2012)
Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: Rationale for dosing recommendations
Mark Lebwohl et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Christopher E. M. Griffiths et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Excessive Body Weight and Smoking Associates with a High Risk of Onset of Plaque Psoriasis
Katarina Wolk et al.
ACTA DERMATO-VENEREOLOGICA (2009)
Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome
R. J. B. Driessen et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women
M. Sumarac-Dumanovic et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL-12/23p40, in Patients With Moderate to Severe Plaque Psoriasis
Yaowei Zhu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impact of Body Mass Index and Obesity on Clinical Response to Systemic Treatment for Psoriasis
Luigi Naldi et al.
DERMATOLOGY (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi et al.
LANCET (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Kim A. Papp et al.
LANCET (2008)
Prevalence of cardiovascular risk factors in patients with psoriasis
Andrea L. Neimann et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study
L Naldi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Medical progress - Psoriasis
MP Schon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
